DPT, Hib, HBV vaccine (CSL/Merck & Co)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDPT, Hib, HBV vaccine (CSL/Merck & Co)
Drug Alias NamePentavax
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5] 
Global Approved IndicationsHepatitis BTetanusDiphtheria +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2000/04/01
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl LtdMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHepatitis BTetanusDiphtheria +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA11
Related LinksN/A